Table 2 Mean Change in individual parameters of metabolic syndrome after 12 weeks of treatment in three treatment groups from baseline (Intention to treat Analysis)

Weight (kg)

−0.6 ± 3.1

0.338

1.1 ± 1.9

0.016^f

−0.4 ± 1.7

0.324

0.048^c, 0.970^d, 0.129^e

BMI (kg/m²)

−0.1 ± 1.4

0.663

0.4 ± 0.7

0.016^f

−0.2 ± 0.7

0.370

0.186^c, 0.995^d, 0.210^e

Waist circumference (cm)

−0.9 ± 4.0

0.314

1.9 ± 2.7

0.003^f

0.9 ± 2.3

0.119

0.013^c, 0.200^d, 0.606^e

FPG (mg/dl)

2.2 ± 10.0

0.312

15.2 ± 19.2

0.002^f

20.5 ± 17.4

<0.001^f

0.021^c, 0.002^d,0.577^e

Triglycerides (mg/dl)

1.1 ± 43.3

0.903

44.3 ± 45.4

<0.001^f

53.3 ± 36.9

<0.001^f

0.004^c, 0.001^d, 0.798^e

HDL (mg/dl)

−1.7 ± 6.6

0.221

−1.9 ± 4.6

0.060

−1.5 ± 9.6

0.544

0.992^c, 0.994^d, 0.974^e

SBP (mm Hg)

0.0 ± 8.6

1.000

1.7 ± 6.7

0.257

5.1 ± 6.3

0.005^f

0.725^c, 0.094^d, 0.354^e

DBP (mm Hg)

0.3 ± 7.9

0.876

1.7 ± 4.2

0.077

4.1 ± 5.5

0.009^f

0.546^c, 0.085^d, 0.475^e

Total Cholesterol (mg/dl)

1.4 ± 29.2

0.816

21.8 ± 25.2

0.001^f

24.0 ± 29.5

0.005^f

0.049^c, 0.042^d, 0.970^e

LDL (mg/dl)

−5.9 ± 28.3

0.324

6.6 ± 20.0

0.146

9.8 ± 11.6

0.004^f

0.151^c, 0.079^d, 0.898^e